These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 15331547)

  • 21. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats.
    Wang P; Lloyd SG; Zeng H; Bonen A; Chatham JC
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2102-10. PubMed ID: 15615844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketones can become the major fuel source for the heart but do not increase cardiac efficiency.
    Ho KL; Karwi QG; Wagg C; Zhang L; Vo K; Altamimi T; Uddin GM; Ussher JR; Lopaschuk GD
    Cardiovasc Res; 2021 Mar; 117(4):1178-1187. PubMed ID: 32402081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel role of endothelial autophagy as a regulator of myocardial fatty acid oxidation.
    Altamimi TR; Chowdhury B; Singh KK; Zhang L; Mahmood MU; Pan Y; Quan A; Teoh H; Verma S; Lopaschuk GD
    J Thorac Cardiovasc Surg; 2019 Jan; 157(1):185-193. PubMed ID: 30195591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids.
    DeGrado TR; Kitapci MT; Wang S; Ying J; Lopaschuk GD
    J Nucl Med; 2006 Jan; 47(1):173-81. PubMed ID: 16391202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy.
    Pillutla P; Hwang YC; Augustus A; Yokoyama M; Yagyu H; Johnston TP; Kaneko M; Ramasamy R; Goldberg IJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1229-35. PubMed ID: 15701679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.
    Wright JJ; Kim J; Buchanan J; Boudina S; Sena S; Bakirtzi K; Ilkun O; Theobald HA; Cooksey RC; Kandror KV; Abel ED
    Cardiovasc Res; 2009 May; 82(2):351-60. PubMed ID: 19147655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency.
    Altamimi TR; Gao S; Karwi QG; Fukushima A; Rawat S; Wagg CS; Zhang L; Lopaschuk GD
    Metabolism; 2019 Sep; 98():37-48. PubMed ID: 31202835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity.
    Yan J; Young ME; Cui L; Lopaschuk GD; Liao R; Tian R
    Circulation; 2009 Jun; 119(21):2818-28. PubMed ID: 19451348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice.
    Aasum E; Hafstad AD; Severson DL; Larsen TS
    Diabetes; 2003 Feb; 52(2):434-41. PubMed ID: 12540618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter.
    Belke DD; Larsen TS; Gibbs EM; Severson DL
    Am J Physiol Endocrinol Metab; 2001 Mar; 280(3):E420-7. PubMed ID: 11171596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty acid metabolism in hearts containing elevated levels of CoA.
    Lopaschuk GD; Hansen CA; Neely JR
    Am J Physiol; 1986 Mar; 250(3 Pt 2):H351-9. PubMed ID: 3953832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin.
    Hafstad AD; Solevåg GH; Severson DL; Larsen TS; Aasum E
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1763-9. PubMed ID: 16327015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competition between lactate and fatty acids as sources of ATP in the isolated working rat heart.
    Schönekess BO
    J Mol Cell Cardiol; 1997 Oct; 29(10):2725-33. PubMed ID: 9344767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of high-fat diet on myocardial lipid metabolism in failing and nonfailing hearts with angiotensin II-mediated cardiac remodeling in mice.
    Pellieux C; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
    Am J Physiol Heart Circ Physiol; 2012 May; 302(9):H1795-805. PubMed ID: 22408021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.
    Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride.
    Lahey R; Wang X; Carley AN; Lewandowski ED
    Circulation; 2014 Nov; 130(20):1790-9. PubMed ID: 25266948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats.
    Atkinson LL; Kozak R; Kelly SE; Onay Besikci A; Russell JC; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E923-30. PubMed ID: 12464581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High rates of residual fatty acid oxidation during mild ischemia decrease cardiac work and efficiency.
    Folmes CD; Sowah D; Clanachan AS; Lopaschuk GD
    J Mol Cell Cardiol; 2009 Jul; 47(1):142-8. PubMed ID: 19303418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct effects of short- and long-term leptin treatment on glucose and fatty acid uptake and metabolism in HL-1 cardiomyocytes.
    Palanivel R; Eguchi M; Shuralyova I; Coe I; Sweeney G
    Metabolism; 2006 Aug; 55(8):1067-75. PubMed ID: 16839843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.